Puma Biotechnology

About:

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Website: http://www.pumabiotechnology.com

Top Investors: OrbiMed, T. Rowe Price, Silicon Valley Bank, Sahsen Ventures, Adage Capital Management

Description:

Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.